Add to ORKG博士(医学) 乙第2900号(主論文の要旨、要約、審査結果の要旨、本文)著者名:大下隆司・河野美帆,タイトル:12～17歳の大うつ病性障害患者に対する第一選択薬としてのescitalopramの臨床的有用性に関する後方視的研究,掲載誌:東京女子医科大学雑誌(0040-9022),巻・頁・年:86巻臨時増刊1号 p.E67-E72(2016
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...
Objective: To review the basic pharmacology and published literature regarding escitalopram and cita...
Bernardo Dell’Osso, Chiara Arici, Cristina Dobrea, Giulia Camuri, Beatrice Benatti, A Carl...
Objective: The present study investigated the efficacy and tolerability of escitalopram in the preve...
METHODS This was an 8-week,single arm,open-label,multicenter,prospective,post marketing study.Male a...
Severe depression accounts for one-third of depressed patients. Increasing severity of depression us...
Evidence of efficacy of new drugs is based on clinical studies which include highly selected patient...
Background: Although pharmacological and psychological interventions are both effective for major de...
Abstract Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at ...
BACKGROUND: Although pharmacological and psychological interventions are both effective for major de...
BACKGROUND: Mood and emotional disturbances are common in patients with stroke, and adversely affe...
Escitalopram, the S-enantiomer of citalopram and the most selective of the selective serotonin reupt...
BACKGROUND: Randomized controlled clinical trials have demonstrated that escitalopram is efficacious...
目的 观察艾司西酞普兰治疗儿童青少年抑郁症的临床疗效及安全性.方法对50例儿童青少年抑郁症患者给予艾司西酞普兰治疗4周.于治疗前及治疗后1、2、4周末采用汉密尔顿抑郁量表(HAMD)及汉密尔顿焦虑量表...
Background: The efficacy of selective serotonin reuptake inhibitors (SSRIs) is well established in t...
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...
Objective: To review the basic pharmacology and published literature regarding escitalopram and cita...
Bernardo Dell’Osso, Chiara Arici, Cristina Dobrea, Giulia Camuri, Beatrice Benatti, A Carl...
Objective: The present study investigated the efficacy and tolerability of escitalopram in the preve...
METHODS This was an 8-week,single arm,open-label,multicenter,prospective,post marketing study.Male a...
Severe depression accounts for one-third of depressed patients. Increasing severity of depression us...
Evidence of efficacy of new drugs is based on clinical studies which include highly selected patient...
Background: Although pharmacological and psychological interventions are both effective for major de...
Abstract Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at ...
BACKGROUND: Although pharmacological and psychological interventions are both effective for major de...
BACKGROUND: Mood and emotional disturbances are common in patients with stroke, and adversely affe...
Escitalopram, the S-enantiomer of citalopram and the most selective of the selective serotonin reupt...
BACKGROUND: Randomized controlled clinical trials have demonstrated that escitalopram is efficacious...
目的 观察艾司西酞普兰治疗儿童青少年抑郁症的临床疗效及安全性.方法对50例儿童青少年抑郁症患者给予艾司西酞普兰治疗4周.于治疗前及治疗后1、2、4周末采用汉密尔顿抑郁量表(HAMD)及汉密尔顿焦虑量表...
Background: The efficacy of selective serotonin reuptake inhibitors (SSRIs) is well established in t...
International audienceBACKGROUND: Escitalopram has shown efficacy and tolerability in the prevention...
Objective: To review the basic pharmacology and published literature regarding escitalopram and cita...
Bernardo Dell’Osso, Chiara Arici, Cristina Dobrea, Giulia Camuri, Beatrice Benatti, A Carl...